Intelligence · Clinical Development
Pipeline search results
Programs matching “treprostinil” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 34 pipeline programs matching "treprostinil" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Inhaled Treprostinil
United Therapeutics Europe Ltd
Idiopathic Pulmonary Fibrosis
1 trial -
Inhaled treprostinil
United Therapeutics Europe Ltd
Pulmonary Hypertension
5 trials -
Inhaled treprostinil solution
United Therapeutics Europe Ltd
Pulmonary Hypertension
2 trials -
Oral Treprostinil
United Therapeutics Europe Ltd
Pulmonary Hypertension Associated With Sickle Cell Disease
1 trial -
Oral Treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
2 trials -
Oral treprostinil
United Therapeutics Europe Ltd
Pulmonary Hypertension
2 trials -
Oral treprostinil (UT-15C) sustained release tablets
United Therapeutics Europe Ltd
Pulmonary Hypertension
2 trials -
Remodulin (treprostinil sodium) Injection
United Therapeutics Europe Ltd
Peripheral Vascular Disease
1 trial -
Remodulin® (treprostinil sodium) Injection
United Therapeutics Europe Ltd
Critical Limb Ischemia
1 trial -
UT-15C (treprostinil diolamine)
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
treprostinil sodium
United Therapeutics Europe Ltd
Liver Transplant
1 trial -
Inhaled Treprostinil
United Therapeutics Europe Ltd
Sarcoidosis
1 trial -
Inhaled Treprostinil (Tyvaso Nebulizer)
United Therapeutics Europe Ltd
COPD (Chronic Obstructive Pulmonary Disease)
1 trial -
Oral treprostinil
United Therapeutics Europe Ltd
Systemic Sclerosis
1 trial -
Parenteral Remodulin (treprostinil) injection
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Treprostinil
United Therapeutics Europe Ltd
Ischemia Reperfusion Injury
1 trial -
Treprostinil Inhalation Solution
United Therapeutics Europe Ltd
Respiratory Distress Syndrome, Adult
1 trial -
oral treprostinil
United Therapeutics Europe Ltd
PAH
1 trial -
treprostinil dienthanolmine sustained release
United Therapeutics Europe Ltd
Critical Limb Ischemia
1 trial -
treprostinil diethanolamine
United Therapeutics Europe Ltd
Systemic Sclerosis
2 trials -
TransCon PEG treprostinil
United Therapeutics Europe Ltd
PAH
1 trial -
Treprostinil Inhalation Powder
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Treprostinil diethanolamine
United Therapeutics Europe Ltd
Hypertension, Pulmonary
2 trials -
UT-15C SR (treprostinil diethanolamine)
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.